Your session is about to expire
← Back to Search
Vitamin C for Type 2 Diabetes
Study Summary
This trial will investigate whether vitamin C can help prevent microvascular disease in type II diabetes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2018 Phase 2 trial • 20 Patients • NCT03148236Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My blood pressure is under control, and I don't have serious heart, kidney, or blood vessel problems.I have signs of blood vessel damage, like pain while walking, heart issues, stroke, or eye/kidney problems.I have diabetes with eye problems and need to control my blood sugar to prevent worsening.This is not a criterion, but rather a label for a specific group within the study. More information is needed to understand the screening criteria for Arm 1.I am willing to use effective birth control methods during the study.I have a mild condition like slightly underactive thyroid.My type 2 diabetes is managed and my HgA1C is 12% or lower.I am unable or unwilling to give consent for the trial.I am in good health with no major illnesses.My blood pressure is under 160/90 mmHg, with or without medication, and I have no significant organ damage.I am between 18 and 65 years old and can consent to treatment.I have had diabetic ketoacidosis or a hyperosmolar coma.I have a mild condition like slightly underactive thyroid.I have type 2 diabetes with HgA1C <= 12% and am on treatment, or I do not have diabetes.I am in good health with no major illnesses.I do not have severe heart, liver, or other systemic diseases.I am between 18 and 65 years old and can legally consent.I do not have type 1 diabetes.I am not pregnant or breastfeeding.My vitamin C levels are above 30 uM before hospital studies.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the ambitions of this clinical experiment?
"This clinical trial is estimated to end in the near future and its primary objective is assessing if acute glycemic control impacts ascorbate leakage. Secondary objectives include determining whether vitamin C supplementation over several weeks can increase RBC Vitamin C concentration, exploring any clinically interpretable relationships between quantifiable outcomes and baseline phenotypes such as sex or other factors, and evaluating the effects of vitamin C supplementation on RBC deformability."
Is the participant registration process open for this trial?
"Affirmative. According to the data hosted on clinicaltrials.gov, this medical trial is currently recruiting participants who were initially posted back in June 14th 2019 and was recently updated as of September 17th 2022. 100 research subjects are required from 2 separate sites for enrolment into the study."
Does the age criteria for this experiment extend beyond twenty years?
"This clinical trial only permits those aged 18 or above and 65 or below to take part, in accordance with the pre-specified inclusion criteria."
How likely is it to experience adverse effects from Vitamin C consumption?
"The safety of Vitamin C was graded at a 1, as this is a Phase 1 trial with limited evidence supporting its efficacy and the absence of data regarding its safety."
What criteria must a person fulfill to be eligible for this research project?
"Eligibility criteria for this trial necessitates that patients must have type 2 diabetes and be between 18 to 65 years old. This study seeks to enrol a total of 100 individuals."
What is the uppermost limit of participants allowed in this clinical experiment?
"Yes, current information on clinicaltrials.gov confirms that the trial is actively seeking participants with a target recruitment of 100 individuals from two distinct medical centres. The study was initiated on June 14th 2019 and most recently updated September 17th 2022."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger